BIOSYSEN Turns Profitable with Expected Net Gain of HK$20 Million for Interim Period

Stock News
昨天

BIOSYSEN (HK: 01355) has issued a positive profit alert, signaling a significant turnaround in its financial performance for the six months ending June 30, 2026.

According to the company's announcement, the group anticipates recording a net profit attributable to shareholders of approximately HK$20 million for the period, a stark contrast to the loss of around HK$13.5 million reported in the same period last year.

This expected swing to profitability is primarily driven by a one-off gain of roughly HK$65.8 million arising from the early termination of a lease agreement, which has substantially boosted the company's bottom line for the reporting period.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10